Brown-Forman reports H1 net sales +11%; raises FY outlook, increases dividend 9%

BROWN FORMAN CORP

2023-Q2 EPS reported $0.99 revenue$2,101,000,000

First half net sales $2.1B (+11% reported, +17% organic); diluted EPS $0.99 (+11%).
Q2 net sales $1.1B (+10% reported, +16% organic); operating income $313M (-2%); EPS $0.47 (-4%).
Board approved 9% dividend increase to $0.2055/share; payable Jan 3, 2023 to holders of record Dec 2, 2022.
Raised FY guidance: organic net sales growth high-single digit; organic operating income high-single digit; tax rate 22-23%; capex $190-$210M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BROWN FORMAN CORP reported second fiscal quarter ended October 31, 2022 results: revenue $1.1 billion, EPS $0.47. Guidance raised.

Period: second fiscal quarter ended October 31, 2022
Revenue: $1.1 billion
EPS: $0.47
Guidance: raised
Result: reported results

Exact text from the filing

For the second quarter, reported net sales 1 increased 10% to $1.1 billion (+16% on an organic basis 2 ) compared to the same prior-year period.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BROWN FORMAN CORP reported six month period ended October 31, 2022 results: revenue $2.1 billion, EPS $0.99. Guidance raised.

Period: six month period ended October 31, 2022
Revenue: $2.1 billion
EPS: $0.99
Guidance: raised
Result: reported results

Exact text from the filing

For the first six months of the fiscal year, reported net sales increased 11% to $2.1 billion (+17% on an organic basis) compared to the same prior-year period.

View on SEC.gov

Browse all earnings releases →

BROWN FORMAN CORP filing history →

Source: SEC EDGAR

accession 0000014693-22-000145

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.